T1000	Speculation 2589 2592	may
E1000	Speculation:T1000 Scope:T1001
T1001	Span 2589 2661	may be an antecedent for both Type 2 diabetes and the Metabolic Syndrome
T1002	Speculation 2550 2559	suggested
E1001	Speculation:T1002 Scope:T1003
T1003	Span 2550 2661	suggested that endothelial dysfunction may be an antecedent for both Type 2 diabetes and the Metabolic Syndrome
T1004	Speculation 2943 2946	may
E1002	Speculation:T1004 Scope:T1005
T1005	Span 2943 2993	may lead to insulin resistance and Type 2 diabetes
T1006	Speculation 2844 2853	suggested
E1003	Speculation:T1006 Scope:T1007
T1007	Span 2844 2993	suggested that ineffective storage of fatty acids by adipocytes due to a defect in the ASP pathway may lead to insulin resistance and Type 2 diabetes
T1008	Negation 1329 1332	not
E1004	Negation:T1008 Scope:T1009
T1009	Span 1329 1408	not support the idea that this can account for all of the cluster abnormalities
T1010	Speculation 544 553	suggested
E1005	Speculation:T1010 Scope:T1011
T1011	Span 453 610	which have been demonstrated to be future predictors of Type 2 diabetes and have also been suggested as key factors in the etiology of the Metabolic Syndrome
T1012	Speculation 1345 1349	idea
E1006	Speculation:T1012 Scope:T1013
T1013	Span 1345 1408	idea that this can account for all of the cluster abnormalities
T1014	Speculation 1192 1201	suggested
E1007	Speculation:T1014 Scope:T1015
T1015	Span 1192 1303	suggested that hyperinsulinemia/insulin resistance is the central etiological factor for the Metabolic Syndrome
T1016	Speculation 1440 1450	suggesting
E1008	Speculation:T1016 Scope:T1017
T1017	Span 1440 1508	suggesting that hyperleptinemia rather than, or synergistically with
T1018	Negation 1472 1483	rather than
E1009	Negation:T1018 Scope:T1019
T1019	Span 1472 1626	rather than, or synergistically with, hyperinsulinemia may play a central role in the genesis of the CVD risk factor cluster that constitutes the syndrome
T1020	Speculation 1679 1686	suggest
E1010	Speculation:T1020 Scope:T1021
T1021	Span 1679 1801	suggest hyperinsulinemia/insulin resistance is an early metabolic lesion in the development of obesity and Type 2 diabetes
T1022	Speculation 1527 1530	may
E1011	Speculation:T1022 Scope:T1023
T1023	Span 1527 1626	may play a central role in the genesis of the CVD risk factor cluster that constitutes the syndrome
T1024	Speculation 2451 2460	suggested
E1012	Speculation:T1024 Scope:T1025
T1025	Span 2375 2536	other potential players in the etiology of the Metabolic Syndrome have been suggested including endothelial dysfunction and acetylation-stimulating protein (ASP)
T1026	Speculation 2247 2253	likely
E1013	Speculation:T1026 Scope:T1027
T1027	Span 2247 2358	likely that a similar sequence occurs in the transition from the prediabetic state to Type 2 diabetes in humans
